Concepedia

Jennifer Cross

JC

Statistics

Publications

12

Citations

343

H-Index

12

Active since

2003

Affiliations

University of British Columbia(Current)

Inimex Pharmaceuticals (Canada)

Jennifer Cross is an author at University of British Columbia specializing in life sciences, immunology, and signal transduction.

ORCID

Publications per year

2003–2022

12

Publications

12

Characterization of <scp>AQX</scp>‐1125, a small‐molecule <scp>SHIP1</scp> activator

Grant R. Stenton, Lloyd Mackenzie, Patrick Tam et al. · British Journal of Pharmacology · 2012 · 63 citations · Full text

, , +17

Characterization of <scp>AQX</scp>‐1125, a small‐molecule <scp>SHIP1</scp> activator

Grant R. Stenton, Lloyd Mackenzie, Patrick Tam et al. · British Journal of Pharmacology · 2012 · 50 citations · Full text

, , +17

Topical resiquimod promotes priming of CTL to parenteral antigens

Brent A. Chang, Jennifer Cross, Hossain M. Najar et al. · Vaccine · 2009 · 43 citations

, , +8

Disruption of β-catenin/CBP signaling inhibits human airway epithelial–mesenchymal transition and repair

Fatemeh Moheimani, Hollis M. Roth, Jennifer Cross et al. · The International Journal of Biochemistry & Cell Biology · 2015 · 42 citations

, , +12

CD45 Regulates TLR-Induced Proinflammatory Cytokine and IFN-β Secretion in Dendritic Cells

Jennifer Cross, Katharine A. Kott, Tatjana Miletić et al. · The Journal of Immunology · 2008 · 32 citations · Full text

, , +17

1–5 of 12